Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727585 | SCV000854831 | uncertain significance | not provided | 2018-03-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001213786 | SCV001385436 | likely pathogenic | Charcot-Marie-Tooth disease type 2 | 2019-11-04 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with arginine at codon 489 of the LMNA protein (p.Leu489Arg). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of laminopathies (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 592239). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |